|
|
Volumn 23, Issue 2, 2000, Pages 143-148
|
|
Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (Irinotecan) for advanced 5-FU-resistant colorectal cancer: An open-label multicenter phase II study
a
|
|
Author keywords
Colorectal cancer; Irinotecan; Prophylactic treatment of delayed diarrhea; Tiorfan
|
|
Indexed keywords
ANTIDIARRHEAL AGENT;
FLUOROURACIL;
IRINOTECAN;
THIORPHAN;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG INFUSION;
DRUG SAFETY;
FEMALE;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MULTICENTER STUDY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
DIARRHEA;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0033636989
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-200004000-00008 Document Type: Article |
|
Times cited : (27)
|
|
References (20)
|
